The role of macrophage podosomes in Ebola virus pathogenesis
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1R21AI151717-01A1
Grant search
Key facts
Disease
EbolaStart & end year
20202022Known Financial Commitments (USD)
$297,000Funder
National Institutes of Health (NIH)Principal Investigator
ASSISTANT PROFESSOR Olena ShtankoResearch Location
United States of AmericaLead Research Institution
TEXAS BIOMEDICAL RESEARCH INSTITUTEResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
PROJECT SUMMARY Ebola virus (EBOV) is an emerging, highly pathogenic virus associated with increasingly more frequent outbreaks of hemorrhagic disease in human populations. Approved countermeasures to prevent or treat EBOV disease are currently limited. Macrophages are the initial cells targeted by EBOV, and yet, little is known about the exact nature of EBOV-macrophage surface interactions and subsequent uptake into the cell. Due to their migratory properties, macrophages are also believed to rapidly disseminate the virus to distant tissues and organs despite the lack of experimental evidence. We have preliminary data showing that EBOV depends on podosomes, mechanosensitive adhesive structures used by macrophages to migrate through tissues and sample antigens, to enter macrophages. The data also shows that EBOV replication increases macrophage locomotion through a fibrillar 3D matrix and reduces podosome number, suggesting that the virus actively transforms infiltration of tissues by these cells. This proposal aims to examine the interactions between EBOV and podosomes. In Aim 1, we will determine whether podosomes serve as ports for EBOV entry into human macrophages. In Aim 2, we will characterize migratory and invasive properties of macrophages challenged with EBOV. In Aim 3, we will assess host resistance to systemic infection with EBOV in a mouse model of EBOV disease devoid of functional macrophages. Our findings will establish a new model of interactions between EBOV and macrophages, laying the groundwork for further investigations into pathogenesis of filoviruses. Importantly, these discoveries may lead to new areas of development of novel countermeasures targeting EBOV and related viruses.